Simultaneous uncoupled expression and purification of the Dengue virus NS3 protease and NS2B co-factor domain

被引:18
|
作者
Shannon, A. E. [1 ]
Chappell, K. J. [1 ]
Stoermer, M. J. [2 ]
Chow, S. Y. [2 ]
Kok, W. M. [2 ]
Fairlie, D. P. [2 ]
Young, P. R. [1 ,2 ]
机构
[1] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia
[2] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, St Lucia, Qld 4072, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
Dengue virus; Protease; NS2B-NS3; Cofactor inhibitor; YELLOW-FEVER VIRUS; WEST-NILE-VIRUS; ENZYMATIC CHARACTERIZATION; STRUCTURAL PROTEINS; VIRAL REPLICATION; CLEAVAGE SITES; IN-VITRO; POLYPROTEIN; MUTAGENESIS; FLAVIVIRUS;
D O I
10.1016/j.pep.2015.11.022
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Dengue Virus (DENV) infection is responsible for the world's most significant insect-borne viral disease. Despite an increasing global impact, there are neither prophylactic nor therapeutic options available for the effective treatment of DENV infection. An attractive target for antiviral drugs is the virally encoded trypsin-like serine protease (NS3pro) and its associated cofactor (NS2B). The NS2B NS3pro complex is responsible for cleaving the viral polyprotein into separate functional viral proteins, and is therefore essential for replication. Recombinant expression of an active NS2B-NS3 protease has primarily been based on constructs linking the C-terminus of the approximately 40 amino acid hydrophilic cofactor domain of NS2B to the N-terminus of NS3pro via a flexible glycine linker. The resulting complex can be expressed in high yield, is soluble and catalytically active and has been used for most in vitro screening, inhibitor, and X-ray crystallographic studies over the last 15 years. Despite extensive analysis, no inhibitor drug candidates have been identified yet. Moreover, the effect of the artificial linker introduced between the protease and its cofactor is unknown. Two alternate methods for bacterial expression of non-covalently linked, catalytically active, NS2B-NS3pro complex are described here along with a comparison of the kinetics of substrate proteolysis and binding affinities of substrate-based aldehyde inhibitors. Both expression methods produced high yields of soluble protein with improved substrate proteolysis kinetics and inhibitor binding compared to their glycine-linked equivalent. The non-covalent association between NS2B and NS3pro is predicted to be more relevant for examining inhibitors that target cofactor-protease interactions rather than the protease active site. Furthermore, these approaches offer alternative strategies for the high yield co-expression of other protein assemblies. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:124 / 129
页数:6
相关论文
共 50 条
  • [1] Design and Docking Studies of Peptide Inhibitors as Potential Antiviral Drugs for Dengue Virus Ns2b/Ns3 Protease
    Velmurugan, Devadasan
    Mythily, Udhayakumar
    Rao, Kutumba
    PROTEIN AND PEPTIDE LETTERS, 2014, 21 (08) : 815 - 827
  • [2] Functional determinants of NS2B for activation of Japanese encephalitis virus NS3 protease
    Lin, Cheng-Wen
    Huang, Hong-Da
    Shiu, Shi-Yi
    Chen, Wei-June
    Tsai, Ming-Hong
    Huang, Su-Hua
    Wan, Lei
    Lin, Ying-Ju
    VIRUS RESEARCH, 2007, 127 (01) : 88 - 94
  • [3] Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction
    Wichapong, Kanin
    Pianwanit, Somsak
    Sippl, Wolfgang
    Kokpol, Sirirat
    JOURNAL OF MOLECULAR RECOGNITION, 2010, 23 (03) : 283 - 300
  • [4] IN SILICO DRUG DESIGNING STUDIES ON DENGUE VIRUS NS2B/NS3 PROTEASE
    Sushmitha, H. S.
    Sathyamurthy, Balasubramanian
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (08): : 7784 - 7790
  • [5] Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side
    Lin, Kuan-Hung
    Ali, Akbar
    Rusere, Linah
    Soumana, Djade I.
    Yilmaz, Nese Kurt
    Schiffer, Celia A.
    JOURNAL OF VIROLOGY, 2017, 91 (10)
  • [6] Yellow fever virus NS2B/NS3 protease: Hydrolytic Properties and Substrate Specificity
    Kondo, Marcia Y.
    Oliveira, Lilian C. G.
    Okamoto, Debora N.
    de Araujo, Marina R. T.
    Duarte dos Santos, Claudia N.
    Juliano, Maria A.
    Juliano, Luiz
    Gouvea, Iuri E.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 407 (04) : 640 - 644
  • [7] Co-refolding of a functional complex of Dengue NS3 protease and NS2S co-factor domain and backbone resonance assignment by solution NMR
    Woestenenk, Esmeralda
    Agback, Peter
    Unnerstale, Sofia
    Henderson, Ian
    Agback, Tatiana
    PROTEIN EXPRESSION AND PURIFICATION, 2017, 140 : 16 - 27
  • [8] Identification of novel thiadiazoloacrylamide analogues as inhibitors of dengue-2 virus NS2B/NS3 protease
    Liu, Hailong
    Wu, Ruoming
    Sun, Yanyan
    Ye, Yan
    Chen, Jing
    Luo, Xiaomin
    Shen, Xu
    Liu, Hong
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (22) : 6344 - 6352
  • [9] Phosphonate inhibitors of West Nile virus NS2B/NS3 protease
    Skorenski, Marcin
    Milewska, Aleksandra
    Pyrc, Krzysztof
    Sienczyk, Marcin
    Oleksyszyn, Jozef
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2019, 34 (01) : 8 - 14
  • [10] Molecular modeling studies on dengue and West Nile Virus NS2B/NS3 protease inhibitor interaction
    K Wichapong
    S Pianwanit
    S Kokpol
    W Sippl
    Chemistry Central Journal, 3 (Suppl 1)